Physician
Rockcastle County Hospital, INC.
Rockcastle County Hospital, INC. was paid $20.27M by Medicaid between Jan 2018 and Dec 2024, across 211 billing codes. Its largest line is 99283, emergency room visit (moderate) — 18% of everything it billed.
33Billing provider infoROCKCASTLE COUNTY HOSPITAL, INC.
MOUNT VERNON, KY 40456
MOUNT VERNON, KY 40456
33aNPI1104890714assigned 02/13/2006
33bProvider typeInternal Medicine Physician
28Total paid$20.27M
24GClaims589,623
24DCodes billed211
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Internal Medicine Physician providers in Kentucky
Rank by total paid#1 of 231
Median peer was paid$77K
This provider vs. median264×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 87,941 | $2.85M | |
| 2019 | 91,902 | $2.87M | |
| 2020 | 77,735 | $2.45M | |
| 2021 | 94,098 | $3.15M | |
| 2022 | 89,169 | $3.03M | |
| 2023 | 82,741 | $3.21M | |
| 2024incomplete | 66,037 | $2.70M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 18% | 25,637 | 20,355 | $3.56M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.7% | 10,395 | 6,430 | $1.77M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 8.1% | 3,601 | 2,302 | $1.64M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 7.3% | 27,990 | 8,506 | $1.48M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4.3% | 2,061 | 1,448 | $881K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 4.3% | 3,133 | 2,885 | $870K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 3.8% | 18,624 | 6,322 | $761K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.7% | 13,997 | 3,995 | $557K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.5% | 2,792 | 1,791 | $507K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.2% | 1,211 | 1,095 | $447K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2.0% | 3,849 | 3,360 | $408K |
| 97535 | Self-care/home management training, each 15 minutes | 1.9% | 13,245 | 4,485 | $388K |
199 more codes
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.8% | 5,890 | $371K |
| 71046 | Radiologic examination, chest; 2 views | 1.6% | 7,119 | $328K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.5% | 4,975 | $313K |
| 80053 | Comprehensive metabolic panel | 1.5% | 37,389 | $299K |
| 36415 | Collection of venous blood by venipuncture | 1.4% | 87,952 | $285K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.4% | 5,408 | $275K |
| 71045 | Radiologic examination, chest; single view | 1.3% | 9,979 | $257K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.1% | 10,446 | $229K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.0% | 4,092 | $212K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 31,848 | $197K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 13,159 | $192K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,756 | $151K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,007 | $142K |
| 80061 | Lipid panel | <1% | 11,180 | $134K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 3,808 | $129K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 1,042 | $122K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 3,051 | $106K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 244 | $102K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 4,200 | $100K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,404 | $99K |
| 73562 | <1% | 2,269 | $94K | |
| 72100 | <1% | 2,049 | $94K | |
| 74018 | <1% | 2,501 | $92K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 3,761 | $89K |
| 97161 | <1% | 1,601 | $87K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,814 | $87K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,377 | $74K |
| 73630 | <1% | 1,664 | $68K | |
| G0378 | Hospital observation service, per hour | <1% | 415 | $68K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 6,029 | $66K |
| A0425 | Ground mileage, per statute mile | <1% | 1,654 | $63K |
| B4035 | Enteral feeding supply kit; pump fed, per day, includes but not limited to feeding/flushing syringe, administration set tubing, dressings, tape | <1% | 2,216 | $61K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 6,839 | $60K |
| 82607 | <1% | 4,120 | $60K | |
| 73030 | <1% | 1,483 | $60K | |
| 87631 | <1% | 874 | $58K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 1,856 | $58K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 432 | $56K |
| 87088 | <1% | 8,432 | $51K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 2,552 | $49K |
| 83880 | <1% | 2,523 | $47K | |
| 87486 | <1% | 1,959 | $46K | |
| 87581 | <1% | 1,952 | $46K | |
| 97016 | <1% | 1,571 | $45K | |
| 73610 | <1% | 1,050 | $39K | |
| 84439 | <1% | 4,573 | $38K | |
| 81001 | <1% | 12,418 | $38K | |
| 84484 | <1% | 5,016 | $36K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,375 | $34K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 73 | $33K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,364 | $33K |
| 72040 | <1% | 678 | $32K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,601 | $29K |
| 97162 | <1% | 374 | $29K | |
| 83690 | <1% | 4,820 | $28K | |
| 73130 | <1% | 798 | $28K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,091 | $27K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 3,532 | $27K |
| 87186 | <1% | 3,809 | $27K | |
| 85027 | <1% | 4,662 | $26K | |
| 73502 | <1% | 793 | $26K | |
| 71271 | <1% | 284 | $25K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 81 | $23K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,812 | $23K |
| 82728 | <1% | 1,710 | $22K | |
| 84436 | <1% | 3,356 | $22K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 3,498 | $21K |
| 87430 | <1% | 1,765 | $20K | |
| 87634 | <1% | 653 | $20K | |
| 87070 | <1% | 2,534 | $19K | |
| 80074 | <1% | 511 | $19K | |
| 99285 | Emergency room visit (most serious) | <1% | 116 | $19K |
| J2704 | Injection, propofol, 10 mg | <1% | 875 | $18K |
| 84479 | <1% | 3,073 | $18K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 52 | $18K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 501 | $18K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 1,105 | $17K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 50 | $16K |
| 87040 | <1% | 1,895 | $15K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 18 | $15K |
| 85378 | <1% | 2,936 | $14K | |
| 97014 | <1% | 634 | $14K | |
| 94010 | <1% | 300 | $13K | |
| 83605 | <1% | 1,471 | $13K | |
| 81025 | <1% | 2,081 | $13K | |
| 93017 | <1% | 93 | $13K | |
| 77080 | <1% | 144 | $13K | |
| 82746 | <1% | 962 | $13K | |
| B4154 | Enteral formula, nutritionally complete, for special metabolic needs, excludes inherited disease of metabolism, includes altered composition of proteins, fats, carbohydrates, vitamins and/or minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit | <1% | 293 | $12K |
| 86140 | <1% | 2,863 | $11K | |
| 82150 | <1% | 1,304 | $11K | |
| 73110 | <1% | 276 | $10K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 5,231 | $10K |
| 82550 | <1% | 1,846 | $10K | |
| 85007 | <1% | 3,364 | $9K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 956 | $9K |
| 82803 | <1% | 723 | $9K | |
| 85610 | <1% | 2,708 | $9K | |
| 83735 | <1% | 1,340 | $8K | |
| J3490 | Unclassified drugs | <1% | 978 | $8K |
| 83550 | <1% | 967 | $7K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 966 | $7K |
| 80299 | <1% | 511 | $7K | |
| 0012A | <1% | 354 | $7K | |
| 76536 | <1% | 55 | $7K | |
| 36600 | <1% | 525 | $7K | |
| 86677 | <1% | 515 | $7K | |
| G0297 | Low dose ct scan (ldct) for lung cancer screening | <1% | 79 | $6K |
| 84145 | <1% | 532 | $6K | |
| 0011A | <1% | 422 | $6K | |
| 72110 | <1% | 101 | $6K | |
| 82553 | <1% | 1,229 | $6K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,171 | $6K |
| 74019 | <1% | 88 | $6K | |
| B9002 | Enteral nutrition infusion pump, any type | <1% | 654 | $5K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 377 | $5K |
| 85651 | <1% | 1,510 | $5K | |
| 83516 | <1% | 257 | $5K | |
| 94664 | <1% | 363 | $5K | |
| 74022 | <1% | 119 | $5K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 89 | $5K |
| 82043 | <1% | 918 | $5K | |
| 82570 | <1% | 802 | $5K | |
| 86665 | <1% | 155 | $4K | |
| 80320 | <1% | 447 | $4K | |
| 84550 | <1% | 870 | $4K | |
| 82948 | <1% | 1,095 | $4K | |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 2,364 | $4K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 24 | $4K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 15 | $4K |
| 85730 | <1% | 952 | $4K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 165 | $3K |
| B4155 | Enteral formula, nutritionally incomplete/modular nutrients, includes specific nutrients, carbohydrates (e.g., glucose polymers), proteins/amino acids (e.g., glutamine, arginine), fat (e.g., medium chain triglycerides) or combination, administered through an enteral feeding tube, 100 calories = 1 unit | <1% | 1,108 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 110 | $3K |
| 71250 | <1% | 22 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 110 | $3K |
| 84703 | <1% | 452 | $3K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | <1% | 97 | $3K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 12 | $3K |
| E0776 | Iv pole | <1% | 1,995 | $3K |
| 84403 | <1% | 132 | $3K | |
| 72072 | <1% | 44 | $3K | |
| 73080 | <1% | 68 | $3K | |
| 84146 | <1% | 175 | $3K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 832 | $3K |
| 86038 | <1% | 287 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,096 | $3K |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,214 | $2K |
| 94060 | <1% | 16 | $2K | |
| 92526 | <1% | 27 | $2K | |
| 87081 | <1% | 364 | $2K | |
| 86308 | <1% | 513 | $2K | |
| 87899 | <1% | 180 | $2K | |
| 94799 | <1% | 735 | $2K | |
| 71270 | <1% | 27 | $2K | |
| 86664 | <1% | 146 | $2K | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 28 | $2K |
| 86663 | <1% | 146 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,336 | $2K |
| 74230 | <1% | 42 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 14 | $1K |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,349 | $1K |
| 80076 | <1% | 153 | $1K | |
| A0426 | Ambulance service, advanced life support, non-emergency transport, level 1 (als 1) | <1% | 1,641 | $924.73 |
| 84132 | <1% | 237 | $781.33 | |
| 12001 | <1% | 14 | $748.80 | |
| 71101 | <1% | 19 | $714.04 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 351 | $666.06 |
| 86762 | <1% | 46 | $613.11 | |
| 86735 | <1% | 46 | $559.62 | |
| 86765 | <1% | 46 | $552.30 | |
| 73590 | <1% | 19 | $530.10 | |
| 87522 | Neg quan hep c or qual rna | <1% | 16 | $523.60 |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 14 | $505.52 |
| 96376 | <1% | 14 | $495.36 | |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | <1% | 55 | $470.47 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 274 | $440.46 |
| 83540 | <1% | 65 | $405.55 | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 17 | $368.93 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 557 | $355.16 |
| 84702 | <1% | 32 | $298.75 | |
| 80069 | <1% | 55 | $274.88 | |
| 0013A | <1% | 18 | $271.38 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 30 | $264.48 |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 19 | $262.07 |
| 99307 | <1% | 13 | $210.37 | |
| 86255 | <1% | 32 | $170.25 | |
| 86430 | <1% | 26 | $159.28 | |
| 82272 | <1% | 13 | $135.97 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 122 | $131.48 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 226 | $85.32 |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 40 | $84.18 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 47 | $82.04 |
| 94760 | <1% | 24 | $64.26 | |
| 0001A | <1% | 22 | $46.70 | |
| 84156 | <1% | 14 | $33.67 | |
| 81003 | <1% | 15 | $29.25 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 62 | $21.78 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 15 | $5.02 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBASTIN, CHRISTOPHER (CFO)
| Provider | Location | Paid |
|---|---|---|
| Rockcastle County Hospital, INC. | Mount Vernon, KY | $3.42M |
| Rockcastle County Hospital, INC. | Mount Vernon, KY | $208K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.